{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:16Z","timestamp":1787028616015,"version":"build-2736575974"},"reference-count":50,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T00:00:00Z","timestamp":1618704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The current data on rates and geographic distribution of vasculitis mortality are limited. We aimed to estimate the mortality rates of primary systemic vasculitis and its geographic distribution using recent population data in the United States. The mortality rates of vasculitis from 1999 to 2019 were obtained from the Center for Disease Control (CDC) Wonder Multiple Cause of Death (MCD). The age-adjusted rates per million for vasculitis as MCD and as an underlying cause of death (UCD) were calculated by state using demographics. A joinpoint regression analysis was applied to evaluate trends over time. The age-adjusted mortality rate of vasculitis as MCD was 4.077 (95% CI: 4.029\u20134.125) and as a UCD was 1.888 per million (95% CI: 1.855\u20131.921). Since 1999, mortality rates have progressively decreased. The age-adjusted mortality rate was higher in females than in males. The highest mortality rate for vasculitis as MCD was in White patients (4.371; 95% CI: 4.317\u20134.424). The northern states and areas with lower populations had higher mortality rates. We found a trend of progressive decreases in the mortality rates of vasculitis, as well as gender, racial, and geographic disparities. Further analyses are warranted to better understand the factors associated with these disparities in order to implement targeted public health interventions to decrease them.<\/jats:p>","DOI":"10.3390\/jcm10081759","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T22:15:13Z","timestamp":1618784113000},"page":"1759","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6255-5306","authenticated-orcid":false,"given":"Alicia","family":"Rodriguez-Pla","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Rossello-Urgell","sequence":"additional","affiliation":[{"name":"Statistics and Epidemiology Consultant, ARJR Media LLC, Scottsdale, AZ 85259, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_2","first-page":"S94","article-title":"Mortality in systemic vasculitis: A systematic review","volume":"26","author":"Phillip","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_3","first-page":"249","article-title":"Long-term survival of patients with Wegener\u2019s granulomatosis","volume":"32","author":"Iacovino","year":"2000","journal-title":"J. Insur. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archinte.1968.03640060068013","article-title":"Combined corticosteroid and azathioprine therapy in 2 patients with Wegener\u2019s granulomatosis","volume":"121","author":"Norton","year":"1968","journal-title":"Arch. Intern Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM197104292841703","article-title":"Cyclophosphamide therapy in Wegener\u2019s granulomatosis","volume":"284","author":"Novack","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM197112302852701","article-title":"Effect of cyclophosphamide upon the immune response in Wegener\u2019s granulomatosis","volume":"285","author":"Fauci","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RHU.0b013e3181571944","article-title":"Lamivudine in the Treatment of Hepatitis B Virus-Related Polyarteritis Nodosa","volume":"13","author":"Auguet","year":"2007","journal-title":"JCR J. Clin. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/archdischild-2020-319810","article-title":"Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis","volume":"106","author":"Friedman","year":"2021","journal-title":"Arch. Dis. Child."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/RHU.0000000000000381","article-title":"Predictors of Dissection in Aortic Aneurysms from Giant Cell Arteritis","volume":"22","author":"Kermani","year":"2016","journal-title":"JCR J. Clin. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1212\/WNL.43.9.1839","article-title":"Geographic distribution of stroke mortality in the United States: 1939\u20131941 to 1979\u20131981","volume":"43","author":"Lanska","year":"1993","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMc1711031","article-title":"Trial of Tocilizumab in Giant-Cell Arteritis","volume":"377","author":"Akiyama","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2307\/4592347","article-title":"Mortality and Geographic Distribution of Arteriosclerotic Heart Disease: Recent Changes 1950\u20131960","volume":"80","author":"Hechter","year":"1965","journal-title":"Public Health Rep. (1896\u20131970)"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rodriguez-Pla, A., and Simms, R.W. (2019). Geographic disparity in systemic sclerosis mortality in the United States: 1999\u20132017. J. Scleroderma Relat. Disord.","DOI":"10.1177\/2397198319869566"},{"key":"ref_15","unstructured":"Centers for Disease Control and Prevention, and National Center for Health Statistics (2020, December 25). Multiple Cause of Death 1999\u20132019. On CDC WONDER Online Database, Released in 2020. Data are from the Multiple Cause of Death Files, 1999\u20132019, as Compiled from Data Provided by the 57 Vital Statistics Jurisdictions through the Vital Statistics Cooperative Program, Available online: http:\/\/wonder.cdc.gov\/mcd-icd10.html."},{"key":"ref_16","unstructured":"Centers for Disease Control and Prevention, and National Center for Health Statistics (2020, December 25). Underlying Cause of Death 1999\u20132019. On CDC WONDER Online Database, Released in 2020. Data are from the Multiple Cause of Death Files, 1999\u20132019, as Compiled from Data Provided by the 57 Vital Statistics Jurisdictions through the Vital Statistics Cooperative Program, Available online: http:\/\/wonder.cdc.gov\/ucd-icd10.html."},{"key":"ref_17","unstructured":"(2020, December 25). Joinpoint Regression Program, VA, 2020. Statistical Research and Applications Branch. National Cancer Institute, Available online: https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"key":"ref_18","first-page":"1786","article-title":"Vasculitis as Underlying Cause of Death in the United States: 1999\u20132010","volume":"66","author":"Monach","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_19","first-page":"1718","article-title":"Geographic Disparities in Mortality Rates of Vasculitis in the United States: 1999 to 2017 (abstract)","volume":"71","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semarthrit.2015.07.009","article-title":"Improved survival in granulomatosis with polyangiitis: A general population-based study","volume":"45","author":"Wallace","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7326\/M19-1564","article-title":"Trends in Antineutrophil Cytoplasmic Autoantibody\u2013Associated Vasculitis-Related Mortality in the United States, 1999 to 2017","volume":"172","author":"Steinberg","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2016-210942","article-title":"Mortality in ANCA-associated vasculitis: Ameta-analysis of observational studies","volume":"76","author":"Tan","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/art.27763","article-title":"Improved outcome in 445 patients with Wegener\u2019s granulomatosis in a German vasculitis center over four decades","volume":"63","author":"Holle","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1503\/cmaj.071541","article-title":"Sex matters: Gender disparities in quality and outcomes of care","volume":"177","author":"Bierman","year":"2007","journal-title":"Can. Med. Assoc. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1503\/cmaj.060730","article-title":"Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest","volume":"177","author":"Birnie","year":"2007","journal-title":"Can. Med. Assoc. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10157-013-0830-8","article-title":"Epidemiology and clinical features of systemic vasculitis","volume":"17","author":"Scott","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2010101058","article-title":"DRB1*15 Allele is a Risk Factor for PR3-ANCA disease in African Americans","volume":"22","author":"Cao","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2215\/CJN.10871016","article-title":"Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986\u20132015","volume":"12","author":"Hogan","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/03009742.2014.982701","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950\u20132009","volume":"44","author":"Chandran","year":"2014","journal-title":"Scand. J. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.1780261007","article-title":"The epidemiology of giant cell arteritis. Report of a Ten-Year Study in Shelby County, Tennessee","volume":"26","author":"Smith","year":"1983","journal-title":"Arthritis Rheum."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3129\/i08-164","article-title":"Giant cell arteritis in Alaska Natives","volume":"44","author":"Mader","year":"2009","journal-title":"Can. J. Ophthalmol."},{"key":"ref_32","first-page":"295","article-title":"Giant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, 1998\u20132003","volume":"42","author":"Ramstead","year":"2007","journal-title":"Can. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bjo.2009.177220","article-title":"Giant cell arteritis in Asians: A comparative study","volume":"95","author":"Pereira","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajo.2006.07.048","article-title":"Giant Cell Arteritis Among Hispanic Americans","volume":"143","author":"Lam","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10067-014-2617-z","article-title":"ANCA-associated vasculitis in Hispanic Americans: An unrecognized severity","volume":"34","author":"Sreih","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"ref_36","first-page":"0060","article-title":"ANCA-associated Vasculitis in Caucasian and Hispanics of the Inland Empire of Southern California","volume":"72","author":"Lee","year":"2020","journal-title":"Arthritis Rheum."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.40034","article-title":"Identification of Functional and Expression Polymorphisms Associated with Risk for Antineutrophil Cytoplasmic Autoantibody\u2013Associated Vasculitis","volume":"69","author":"Merkel","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/rheumatology\/keaa095","article-title":"Incidence and prevalence of giant cell arteritis in Ontario, Canada","volume":"59","author":"Barra","year":"2020","journal-title":"Rheumatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","article-title":"Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden","volume":"74","author":"Mohammad","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant Cell Arteritis in Northwestern Spain","volume":"86","author":"Martin","year":"2007","journal-title":"Medicine"},{"key":"ref_42","first-page":"15","article-title":"The incidence of giant cell arteritis in Jerusalem over a 25-year period: Annual and seasonal fluctuations","volume":"25","author":"Breuer","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","article-title":"Long-term survival of patients with giant cell arteritis in the american college of rheumatology giant cell arteritis classification criteria cohort","volume":"100","author":"Matteson","year":"1996","journal-title":"Am. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.24133","article-title":"Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway","volume":"73","author":"Andersen","year":"2021","journal-title":"Arthritis Rheum."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/rheumatology\/keu483","article-title":"Inpatient complications in patients with giant cell arteritis: Decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency","volume":"54","author":"Unizony","year":"2015","journal-title":"Rheumatology"},{"key":"ref_46","first-page":"1385","article-title":"Mortality among Patients with Giant Cell Arteritis: A Large-scale Population-based Cohort Study","volume":"47","author":"Tiosano","year":"2019","journal-title":"J. Rheumatol."},{"key":"ref_47","first-page":"e13837","article-title":"Inpatient burden and mortality of heatstroke in the United States","volume":"75","author":"Kaewput","year":"2021","journal-title":"Int. J. Clin. Pr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1377\/hlthaff.2019.00722","article-title":"Higher US Rural Mortality Rates Linked to Socioeconomic Status, Physician Shortages, And Lack Of Health Insurance","volume":"38","author":"Gong","year":"2019","journal-title":"Health Aff."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12963-016-0082-4","article-title":"Improving the usefulness of US mortality data: New methods for reclassification of underlying cause of death","volume":"14","author":"Foreman","year":"2016","journal-title":"Popul. Health Metr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2105\/AJPH.2009.180273","article-title":"Burden of Mortality Associated with Autoimmune Diseases Among Females in the United Kingdom","volume":"100","author":"Thomas","year":"2010","journal-title":"Am. J. Public Health"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/8\/1759\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:49:24Z","timestamp":1760161764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/8\/1759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,18]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["jcm10081759"],"URL":"https:\/\/doi.org\/10.3390\/jcm10081759","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,18]]}}}